247 related articles for article (PubMed ID: 18930602)
1. Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study.
Pignol JP; Rakovitch E; Keller BM; Sankreacha R; Chartier C
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1482-8. PubMed ID: 18930602
[TBL] [Abstract][Full Text] [Related]
2. First report of a permanent breast 103Pd seed implant as adjuvant radiation treatment for early-stage breast cancer.
Pignol JP; Keller B; Rakovitch E; Sankreacha R; Easton H; Que W
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):176-81. PubMed ID: 16182464
[TBL] [Abstract][Full Text] [Related]
3. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
[TBL] [Abstract][Full Text] [Related]
4. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
5. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract][Full Text] [Related]
6. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
[TBL] [Abstract][Full Text] [Related]
7. A radiation badge survey for family members living with patients treated with a (103)Pd permanent breast seed implant.
Keller BM; Pignol JP; Rakovitch E; Sankreacha R; O'Brien P
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):267-71. PubMed ID: 17967512
[TBL] [Abstract][Full Text] [Related]
8. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608
[TBL] [Abstract][Full Text] [Related]
9. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
10. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
[TBL] [Abstract][Full Text] [Related]
11. A permanent breast seed implant as partial breast radiation therapy for early-stage patients: a comparison of palladium-103 and iodine-125 isotopes based on radiation safety considerations.
Keller B; Sankreacha R; Rakovitch E; O'brien P; Pignol JP
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):358-65. PubMed ID: 15890575
[TBL] [Abstract][Full Text] [Related]
12. Permanent breast seed implant for partial breast radiotherapy after partial mastectomy for favorable breast cancer: Technique, results, and applications to various seroma presentations.
Crook J; Hilts M; Batchelar D; Milette MP; Kozeniowski M; Pilote L; Pignol JP
Brachytherapy; 2019; 18(4):510-520. PubMed ID: 31109871
[TBL] [Abstract][Full Text] [Related]
13. Report on the Clinical Outcomes of Permanent Breast Seed Implant for Early-Stage Breast Cancers.
Pignol JP; Caudrelier JM; Crook J; McCann C; Truong P; Verkooijen HA
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):614-21. PubMed ID: 26461003
[TBL] [Abstract][Full Text] [Related]
14. Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule.
Wallace M; Martinez A; Mitchell C; Chen PY; Ghilezan M; Benitez P; Brown E; Vicini F
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):531-6. PubMed ID: 19775830
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
Kuske RR; Winter K; Arthur DW; Bolton J; Rabinovitch R; White J; Hanson W; Wilenzick RM
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):45-51. PubMed ID: 16503383
[TBL] [Abstract][Full Text] [Related]
16. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
[TBL] [Abstract][Full Text] [Related]
17. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
Vicini FA; Chen P; Wallace M; Mitchell C; Hasan Y; Grills I; Kestin L; Schell S; Goldstein NS; Kunzman J; Gilbert S; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1124-30. PubMed ID: 17967306
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.
Kaufman SA; DiPetrillo TA; Price LL; Midle JB; Wazer DE
Brachytherapy; 2007; 6(4):286-92. PubMed ID: 17991625
[TBL] [Abstract][Full Text] [Related]
19. Caesium(137) implant as sole radiation therapy for operable breast cancer: a phase II trial.
Fentiman IS; Deshmane V; Tong D; Winter J; Mayles H; Chaudary MA
Radiother Oncol; 2004 Jun; 71(3):281-5. PubMed ID: 15172143
[TBL] [Abstract][Full Text] [Related]
20. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma.
Chen PY; Vicini FA; Benitez P; Kestin LL; Wallace M; Mitchell C; Pettinga J; Martinez AA
Cancer; 2006 Mar; 106(5):991-9. PubMed ID: 16421922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]